Citigroup Inc Gsk PLC Transaction History

Citigroup Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 10, 2022	BUY	$42.05 - $47.77 $183,464 - $208,420	4,363 Added 2.48%	180,538 $7.86 Million
Q1 2022 May 12, 2022	SELL	$40.23 - $47.74 $29.4 Million - $34.9 Million	-731,242 Reduced 80.59%	176,175 $7.67 Million
Q4 2021 Feb 10, 2022	BUY	$38.88 - $45.31 $27.9 Million - $32.5 Million	718,058 Added 379.2%	907,417 $40 Million
Q3 2021 Nov 10, 2021	BUY	$38.79 - $43.16 $7.35 Million - $8.17 Million	189,359 New	189,359 $7.24 Million

176K

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $68.3B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

Stay updated on Citigroup Inc with notifications on news.